April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Patient-Specific Characterization of Myopic PRK Outcomes Using Finite Element Modeling (FEM)
Author Affiliations & Notes
  • A. Sinha Roy
    Opthamology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio
  • W. J. Dupps, Jr.
    Opthamology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  A. Sinha Roy, Co-Inventor in a Pending Patent Application on FEM modeling of Corneal Biomechanics, P; W.J. Dupps, Jr., Co-Invenor in a Pending Patent Application on FEM modeling of corneal biomechanics, P.
  • Footnotes
    Support  This work was supported by a Research to Prevent Blindness Challenge Grant, Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1759. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Sinha Roy, W. J. Dupps, Jr.; Patient-Specific Characterization of Myopic PRK Outcomes Using Finite Element Modeling (FEM). Invest. Ophthalmol. Vis. Sci. 2009;50(13):1759.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Analyze topographic outcomes after myopic PRK using patient-specific FEM model

Methods: : A 3-D FEM model of the cornea was constructed from Atlas patient topography and Visante OCT maps. Myopic PRK with mitomycin C 0.02% and programmed correction of -8.05D sphere change was simulated using Munnerlynn’s equation. The cornea was modeled as hyperelastic tissue with collagen fibers oriented orthogonally. The assumed elasticity of the native cornea and IOP was also perturbed in post-PRK model as the IOP was elevated post-PRK due to topical steroids. Axial power difference maps were constructed to compare pre- with post-PRK FEM and in vivo outcomes.

Results: : The pre- and post-PRK IOP was normal. At 1 month follow-up, the IOP nearly doubled due to topical steroids. Once steroids were discontinued and topical antihypertensives added, the IOP and axial power returned to normal (2 month follow-up). The axial power differences are similar though the magnitudes differ from pre to post-PRK after IOP spike at 1 month follow-up (see figure). In vivo, the average power difference in the central 3 mm zone was -6.65D. If FEM elasticity was assumed to be unchanged from pre to post-PRK, the power difference was -7.98D (20% difference from in vivo). If the tissue was made less stiff than pre-PRK tissue stiffness values by 25%, the power difference was -6.75D (1.5% difference from in vivo). After post-PRK IOP returned to normal, the cornea flattened by 0.82D in vivo. When the elasticity was left unchanged after PRK, the flattening was 1.24D. When the elasticity was reduced by 25%, the flattening predicted by FEM was 1.03D. Thus, a less stiff cornea and steepening with IOP elevation after PRK were predicted by FEM.

Conclusions: : FEM can be useful to predict refractive change after PRK using patient specific topography. Iterative modeling to match clinical outcomes predicts a weaker cornea after high myopic PRK. This highlights the need to measure elastic properties in vivo to improve patient-specific FEM results.

Keywords: refractive surgery: PRK • computational modeling • refractive error development 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×